Mainz Biomed announced the appointment of Tarrin Khairi-Taraki as Vice President of Commercial Operations, EMEA. Tarrin will play a pivotal role in steering Mainz Biomed’s continued success, focusing on the commercialization of its flagship product, ColoAlert. In his role as Co-Founder and VP of Business Development at Eluthia, Tarrin played a pivotal role in the company’s success.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MYNZ:
- Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations
- Mainz Biomed presents results of ColoFuture study
- Mainz Biomed Presents Groundbreaking Results of ColoFuture Study
- Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark
- Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit